Ease Concerns About Cancer Risk With BP Meds

Questions are cropping up about whether blood pressure meds increase cancer risk...because of a laundry list of recalls and media reports.

Contamination with a probable carcinogen is leading to ongoing recalls with valsartan, irbesartan, losartan, and some combo products.

Now patients are also hearing that some BP meds themselves are linked to cancer...NOT because of a contaminant. Debunk these concerns.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote